The porous thermosensitive imprinted polymer of MW-Ru(IV)-TIIP was prepared in a short time with the aid of a microwave. The structure and morphology of MW-Ru(IV)-TIIP were characterized by ATR-FTIR, SEM-EDS, and BET. The thermosensitive block PDEA- b -P(DEA- co -AM) was introduced into the imprinted polymer preparation system. N-MAM and AA were selected as functional monomers, and stable HIPE Pickering emulsions were prepared under high-speed stirring, combined with multi-field coupling technology. The synthesis process of MW-Ru(IV)-TIIP was studied, and the dosages of template ion, functional monomer, and cross-linking agent, as well as microwave power, polymerization temperature, and polymerization time, were optimized. Under optimal technological conditions, the maximum adsorption capacity of MW-Ru(IV)-TIIP reached 0.20 mmol L −1 at 33°C, and adsorption equilibrium was reached within 240 min. Theoretical studies showed that the adsorption of MW-Ru(IV)-TIIP conformed to the quasi-first-order kinetic model and the Langmuir model. When MW-Ru(IV)-TIIP was applied to a diluted platinum group catalyst leaching solution, its adsorption capacity for MW-Ru(IV)-TIIP to Ru was 0.23 mmol L −1 , and the purity of platinum group metals increased from 53.72% to 76.43% after one adsorption/desorption cycle. After 11 reuses, the adsorption capacity maintained 70.06% of the original capacity, indicating that MW-Ru(IV)-TIIP had good potential in industrial applications.
Nuo Jin,Zilin Wang,Xi Tang,Nianqiang Jin,Xiaohong Wang
The management of diabetic wounds (DWs) continues to pose a significant challenge in the field of medicine. DWs are primarily prevented from healing due to damage to macrophage efferocytosis and fibroblast dysfunction. Consequently, a treatment strategy that involves both immunoregulation and the promotion of extracellular matrix (ECM) formation holds promise for healing DWs. Nevertheless, existing treatment methods necessitate complex interventions and are associated with increased costs, for example, the use of cytokines and cell therapy, both of which have limited effectiveness. In this study, a new type of ruthenium (IV) oxide nanoparticles (RNPs)-laden hybrid hydrogel dressing with a double network of Pluronic F127 and F68 has been developed. Notably, the hybrid hydrogel demonstrates remarkable thermosensitivity, injectability, immunoregulatory characteristics, and healing capability. RNPs in hydrogel effectively regulate both fibroblasts and macrophages in a cascade manner, stimulating fibroblast differentiation while synergistically enhancing the efferocytosis of macrophage. The immunoregulatory character of the hydrogel aids in restoring the intrinsic stability of the immune microenvironment in the wound and facilitates essential remodeling of the ECM. This hydrogel therefore offers a novel approach for treating DWs through intercellular communication.
危险品化学品经营许可证（带存储）